Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the valsartan/hydrochlorothiazide combination in hypertensive patients not adequately controlled on valsartan alone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Diovan HCT (valsartan/hydrochlorothiazide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED